CareDx insider plans sale of 7,000 common shares

PETER MAAG filed to sell common stock of CDNA.

Rhea-AI Filing Summary

PETER MAAG filed to sell common stock of CDNA. The notice lists a proposed sale of 7,000 shares through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $317,112.60, against 51,734,223 shares outstanding as of the filing. It also details multiple common stock sales over the prior three months, including blocks of 75,653, 46,963, and 27,332 shares, each with corresponding dollar amounts.

Key Figures

Proposed shares to be sold: 7,000 shares Aggregate market value of proposed sale: $317,112.60 Shares outstanding: 51,734,223 shares +3 more

6 metrics

Proposed shares to be sold 7,000 shares Planned common stock sale listed through Morgan Stanley Smith Barney LLC Executive Financial Services

Aggregate market value of proposed sale $317,112.60 Value associated with the 7,000-share proposed common stock sale

Shares outstanding 51,734,223 shares Outstanding common stock referenced for the issuer

Recent block sale 75,653 shares for $3,576,851.19 Common stock sale dated 08/04/2026 by Peter Maag

Recent block sale 46,963 shares for $2,178,945.34 Common stock sale dated 08/05/2026 by Peter Maag

Recent block sale 27,332 shares for $1,252,491.63 Common stock sale dated 08/07/2026 by Peter Maag

Key Terms

Restricted Stock, Executive Financial Services, Securities To Be Sold, Securities Sold During The Past 3 Months

4 terms

Restricted Stock financial

"Common | 02/03/2024 | Restricted Stock | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

Securities To Be Sold financial

"144: Securities To Be Sold"

Securities Sold During The Past 3 Months financial

"144: Securities Sold During The Past 3 Months"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CDNA Form 144 filing by Peter Maag disclose?

The filing discloses a planned sale of 7,000 CDNA common shares with an aggregate market value of $317,112.60, plus a history of several sizeable common stock sales over the past three months.

How many CDNA shares is Peter Maag currently planning to sell under this notice?

The notice lists a proposed sale of 7,000 CDNA common shares. These shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, with the filing citing an aggregate market value of $317,112.60 for this block.

What is the outstanding share count of CDNA referenced in this Form 144?

The document cites 51,734,223 CDNA common shares outstanding. This figure provides context for the relative size of the 7,000-share proposed sale disclosed in the notice.

Which broker is listed for the proposed CDNA stock sale in this filing?

The proposed 7,000-share CDNA sale is listed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, with trading noted on NASDAQ.

What prior CDNA stock sales by Peter Maag are reported in the last three months?

The filing reports several CDNA common stock sales, including 75,653 shares for $3,576,851.19, 46,963 shares for $2,178,945.34, and 27,332 shares for $1,252,491.63, along with additional 6,902–7,000 share transactions.

On which market is the CDNA common stock referenced in this Form 144 traded?

The common stock referenced in the notice is traded on NASDAQ. The filing associates the proposed 7,000-share sale and the issuer’s 51,734,223 outstanding shares with this trading venue.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/14/2026 - 06:10 PM Accepted by SEC EDGAR 08/14/2026 - 06:09 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001613855
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CAREDX, INC.
SEC File Number	001-36536
Address of Issuer	8000 Marina Boulevard, Brisbane CALIFORNIA 94005
Phone	415-287-2300
Name of Person for Whose Account the Securities are To Be Sold	PETER MAAG
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7000	317112.60	51734223	08/14/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/03/2024	Restricted Stock	Issuer			1323	02/03/2024	Not Applicable
Common	07/06/2023	Restricted Stock	Issuer			5000	07/06/2023	Not Applicable
Common	07/06/2023	Restricted Stock	Issuer			677	07/06/2023	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
PETER MAAG 8000 Marina Boulevard, Brisbane CA 94005	Common	08/13/2026	7000	329505.40
PETER MAAG 8000 Marina Boulevard, Brisbane CA 94005	Common	08/12/2026	7000	328237.70
PETER MAAG 8000 Marina Boulevard, Brisbane CA 94005	Common	08/11/2026	7000	333851.00
PETER MAAG 8000 Marina Boulevard, Brisbane CA 94005	Common	08/10/2026	6902	328949.32
PETER MAAG 8000 Marina Boulevard, Brisbane CA 94005	Common	08/07/2026	27332	1252491.63
PETER MAAG 8000 Marina Boulevard, Brisbane CA 94005	Common	08/05/2026	46963	2178945.34
PETER MAAG 8000 Marina Boulevard, Brisbane CA 94005	Common	08/04/2026	75653	3576851.19

144: Remarks and Signature

Remarks
Date of Notice	08/14/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Peter Maag
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)